Large gross margins with low barrier to entry = competition coming
Price-to-sales of 1.5 is not unfair. See RELV at http://www.reliv.com/ ... their price-to-sales is 1.3 and yet they are growing their earnings for the past 3 years at a better rate than NTRI, and were profitable every quarter. NUTR has better top-line growth, but RELV has much better bottom-line growth. And the PE for RELV is 22. Like I said, we need 10-fold rev growth for NTRI to grow into the current stock price. And we need more than 10-fold growth to become a compelling buy with good upside potential.
By the way, if you think that their distribution system with dozens of suppliers, a proven glycemic diet that works, an efficient direct marketing infrastructure and at least $1 billion in brand equity spent over 20 years is a low barrier to entry, then you obviously just don't get it.
<<Large gross margins with low barrier to entry = competition coming>>
Well you will be right someday but in real-time, this company just announced tremendous market share gains... they are currently beating the competition BADLY... margins will get better and I would argue significantly better before they get worse...
you are making a long-term argument in the face of tremendous momentum... for now, the price/sales looks too low... someday, maybe this company will be bankrupt because of competition -- but first the company is going to make tons of money...
You said: "And you are an idiot for even suggesting that REVL is a high-growth company"
You looked only at rev growth. I look there too, but I also look at earnings growth which is what really matters.
NTRI... 6/03 = .08, 6/04 = .03, 6/05 = .13 in other words, very choppy, and only about 60% growth over 2 years. Great things are coming? Maybe. Maybe not.
RELV... 6/03 = .06, 6/04 = .05, 6/05 = .13 that's steadier, FASTER growth over 2 years. On top of that, RELV has much better cash flow, consistent profitability, and vastly better value (eg, nearly 1/10 the price to sales).
Good luck with your momo play, and that in-depth analysis.
Please distribute the drugs that you are taking. Past 3 years? This company will grow 5 fold this year. Unparalled ANYWHERE!!! Better top line growth??? $.02 to $0.65 by the end of the year?? Please show me a better growth rate on the bottom line. Anyone that has seriously done the research will expect $1.50+ for '06 which means that this 400 to 500% grower is selling for 20xs next year's earnings. Don't believe it if you like, future buying for the rest of us.